ATE136788T1 - Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius - Google Patents

Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius

Info

Publication number
ATE136788T1
ATE136788T1 AT89909303T AT89909303T ATE136788T1 AT E136788 T1 ATE136788 T1 AT E136788T1 AT 89909303 T AT89909303 T AT 89909303T AT 89909303 T AT89909303 T AT 89909303T AT E136788 T1 ATE136788 T1 AT E136788T1
Authority
AT
Austria
Prior art keywords
infectious disease
new virus
virus responsible
virus
fabricius
Prior art date
Application number
AT89909303T
Other languages
English (en)
Inventor
David B Snyder
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE136788T1 publication Critical patent/ATE136788T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT89909303T 1988-08-02 1989-08-02 Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius ATE136788T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/227,311 US5064646A (en) 1988-08-02 1988-08-02 Novel infectious bursal disease virus

Publications (1)

Publication Number Publication Date
ATE136788T1 true ATE136788T1 (de) 1996-05-15

Family

ID=22852607

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89909303T ATE136788T1 (de) 1988-08-02 1989-08-02 Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius

Country Status (12)

Country Link
US (1) US5064646A (de)
EP (1) EP0428596B1 (de)
JP (1) JP3148214B2 (de)
KR (1) KR900701314A (de)
AT (1) ATE136788T1 (de)
AU (1) AU631808B2 (de)
CA (1) CA1340931C (de)
DE (1) DE68926300T2 (de)
FI (1) FI100383B (de)
NZ (1) NZ230148A (de)
WO (1) WO1990001336A1 (de)
ZA (1) ZA895867B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
US5518724A (en) * 1988-08-02 1996-05-21 University Of Maryland Infectious bursal disease virus
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine
US5632989A (en) * 1989-10-18 1997-05-27 University Of Maryland Attenuated, live vaccine for Delaware strain IBDV
US5595912A (en) * 1990-05-04 1997-01-21 University Of Maryland College Park Specific DNA and RNA sequences associated with US IBDV variants, vector carrying DNA sequences, host carrying cloned vector, deduced amino acid sequences, vaccine and method of vaccination
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
ES2590912T3 (es) 1997-12-08 2016-11-24 Merck Patent Gmbh Proteínas de fusión heterodiméricas útiles para inmunoterapia dirigida y estimulación general del sistema inmunitario
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
MXPA02001417A (es) 1999-08-09 2002-08-12 Lexigen Pharm Corp Complejos multiples de citosina-anticuerpo.
CA2391080A1 (en) 1999-11-12 2001-05-25 Merck Patent Gesellschaft Mit Beschraenkter Haftung Erythropoietin forms with improved properties
HUP0204475A2 (en) 2000-02-11 2003-04-28 Merck Patent Gmbh Enhancing the circulating half-life of antibody-based fusion proteins
KR20030064275A (ko) 2000-06-29 2003-07-31 메르크 파텐트 게엠베하 면역싸이토카인 흡수 증강제와의 조합 치료에 의한항체-싸이토카인 융합 단백질 매개 면역 반응 증강
RU2191825C1 (ru) * 2001-03-07 2002-10-27 Ооо "Биота" Штамм вируса инфекционной бурсальной болезни птиц "био-92" для производства вакцин, диагностических и других биопрепаратов
RU2003129528A (ru) 2001-03-07 2005-04-10 Мерк Патент ГмбХ (DE) Способ экспрессии белков, содержащих в качестве компонента гибридный изотип антитела
WO2002079415A2 (en) 2001-03-30 2002-10-10 Lexigen Pharmaceuticals Corp. Reducing the immunogenicity of fusion proteins
EP1383785B1 (de) 2001-05-03 2011-03-16 Merck Patent GmbH Rekombinanter, tumorspezifischer antikörper und dessen verwendung
DK1454138T3 (da) 2001-12-04 2012-02-13 Merck Patent Gmbh Immunocytokiner med moduleret selektivitet
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
WO2004055056A1 (en) 2002-12-17 2004-07-01 Merck Patent Gmbh Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
WO2005049077A2 (en) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
ES2305886T3 (es) 2003-12-30 2008-11-01 Merck Patent Gmbh Proteinas de fusion de il-7 con porciones de anticuerpo, su preparacion y su empleo.
RU2370276C2 (ru) 2003-12-31 2009-10-20 Мерк Патент Гмбх Fc-ЭРИТРОПОЭТИН СЛИТЫЙ БЕЛОК С УЛУЧШЕННОЙ ФАРМАКОКИНЕТИКОЙ
AU2005206277B2 (en) 2004-01-22 2011-06-23 Merck Patent Gmbh Anti-cancer antibodies with reduced complement fixation
US7670595B2 (en) 2004-06-28 2010-03-02 Merck Patent Gmbh Fc-interferon-beta fusion proteins
CN100360662C (zh) * 2004-09-27 2008-01-09 长江大学 一种传染性法氏囊病基因工程亚单位疫苗的制备方法和应用
US7244432B2 (en) * 2004-12-08 2007-07-17 University Of Maryland Biotechnology Institute Infectious bursal disease virus (IBDV) variant from Georgia
RU2437893C2 (ru) 2004-12-09 2011-12-27 Мерк Патент Гмбх Варианты il-7 со сниженной иммуногенностью
ES2365046T3 (es) 2005-12-30 2011-09-21 Merck Patent Gmbh Anticuerpos anti-cd19 con inmunogenicidad reducida.
PL1966238T3 (pl) 2005-12-30 2012-09-28 Merck Patent Gmbh Warianty interleukiny-12p40 o polepszonej stabilności
SG175233A1 (en) 2009-04-22 2011-11-28 Merck Patent Gmbh Antibody fusion proteins with modified fcrn binding sites

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines

Also Published As

Publication number Publication date
AU4055989A (en) 1990-03-05
JPH04503153A (ja) 1992-06-11
ZA895867B (en) 1990-05-30
US5064646A (en) 1991-11-12
FI100383B (fi) 1997-11-28
NZ230148A (en) 1993-01-27
EP0428596A1 (de) 1991-05-29
DE68926300D1 (de) 1996-05-23
KR900701314A (ko) 1990-12-01
AU631808B2 (en) 1992-12-10
CA1340931C (en) 2000-03-21
DE68926300T2 (de) 1996-10-31
WO1990001336A1 (en) 1990-02-22
JP3148214B2 (ja) 2001-03-19
EP0428596B1 (de) 1996-04-17
FI910497A0 (fi) 1991-02-01
EP0428596A4 (en) 1991-09-04

Similar Documents

Publication Publication Date Title
DE68926300D1 (de) Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DE69029145D1 (de) Für die infektiöse erkrankung der bursa fabricius verantwortlicher virus
FI970071A7 (fi) Eristetty nukleiinihapposekvenssi, joka koodaa HLA-A2:n esittämää tuum orihyljintäantigeeniä
DE3585370D1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
DK76191A (da) Filamentoest haemagglutinin fra b.pertussis
DE69301733D1 (de) Impfstoffe gegen Metazoen-Parasiten
SE7910089L (sv) Vacciner
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
FI972658L (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
FI870500A7 (fi) Reagenssi virus-antigeenin vasta-aineen määrittämiseksi.
UY26616A1 (es) Anticuerpos específicos de fap- alfa humanos
SE8701294D0 (sv) Hiv-peptid
MX9203316A (es) Uso de il-4 para mejorar la respuesta inmune a tetos antigenicos infecciosos.
ATE100859T1 (de) Durch virusneutralisierende und schuetzende monokonale antikoerper erkanntes ibdv vp2 epitop.
RU93012074A (ru) Набор для диагностики гриппа свиней
ATE112855T1 (de) Verfahren und zusammensetzungen betreffend regressions-assoziierte antigene.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee